REFERENCES
1. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med 2014;371:1765-7.
2. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003;237:399-407.
3. Asimakopoulos P, Shaha AR, Nixon IJ, et al. Management of the neck in well-differentiated thyroid cancer. Curr Oncol Rep 2020;23:1.
4. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109-42.
5. Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
6. Orloff LA, Randolph GW. Preoperative imaging for thyroid cancer: beyond ultrasonography. JAMA Otolaryngol Head Neck Surg 2016;142:515-6.
7. Lesnik D, Cunnane ME, Zurakowski D, et al. Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and reoperative patients. Head Neck 2014;36:191-202.
8. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 2009;19:683-9.
9. Eskander A, Noel CW, Griffiths R, et al. Surgeon thyroidectomy case volume impacts disease-free survival in the management of thyroid cancer. Laryngoscope 2023;133 Suppl 4:S1-15.
10. Gonçalves Filho J, Zafereo ME, Ahmad FI, et al. Decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol 2018;44:1671-8.
11. Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Horm Metab Res 2020;52:562-77.
12. Dismukes J, Fazendin J, Obiarinze R, et al. Prophylactic central neck dissection in papillary thyroid carcinoma: all risks, no reward. J Surg Res 2021;264:230-5.
13. Dolidze DD, Shabunin AV, Mumladze RB, et al. A narrative review of preventive central lymph node dissection in patients with papillary thyroid cancer - a necessity or an excess. Front Oncol 2022;12:906695.
14. Iyer NG, Shaha AR. Controversies and challenges in the management of well-differentiated thyroid cancer. Indian J Surg 2009;71:299-307.
15. Moussa AM, Maybody M, Gonzalez-Aguirre AJ, Buicko JL, Shaha AR, Santos E. Thoracic duct embolization in post-neck dissection chylous leakage: a case series of six patients and review of the literature. Cardiovasc Intervent Radiol 2020;43:931-7.
16. Shaha AR. Editorial: complications of neck dissection for thyroid cancer. Ann Surg Oncol 2008;15:397-9.
17. Hay ID, Lee RA, Davidge-Pitts C, Reading CC, Charboneau JW. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy. Surgery 2013;154:1448-54; discussion 1454-5.
18. Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 2012;22:1144-52.
19. Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133.
